NSC |
Compound |
Enrichment |
Correlation |
NSC 643740 |
Null |
0.0112113991710615 |
0.27185294 |
NSC 646125 |
Null |
0.0112113991710615 |
0.0072419276 |
NSC 680715 |
Benzaldehyde, 5-bromo-2-hydroxy- (9CI) |
0.0112113991710615 |
0.18822904 |
NSC 684569 |
Barbituric acid, 5-[3-(4-methoxyphenyl)- 2-propenylidene]-2-thio- |
0.0112113991710615 |
0.07669233 |
NSC 690271 |
ANTINEOPLASTIC-690271 |
0.0112113991710615 |
0.62575389 |
NSC 703174 |
Null |
0.0112113991710615 |
-0.0064268106 |
NSC 726768 |
5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline |
0.0112113991710615 |
0.53817207 |
NSC 736200 |
6-(3-Bromopropyl)-5,6-dihydro3-nitro-5,11-dioxo-9-thiomethyl -11H-indeno[1,2-c]isoquinoline |
0.0112113991710615 |
0.72768062 |
NSC 743862 |
Null |
0.0112113991710615 |
0.19477878 |
NSC 744331 |
(2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd |
0.0112113991710615 |
0.34635195 |